Gynuity Health Projects


Introduction and provision of medical abortion: A tale of two countries in which technology is necessary but not sufficient.

The article examines the commercial, political, regulatory, and legislative history of the introduction of mifepristone-misoprostol in France and the United States. Read the full abstract at Contraception (Apr 2011), Vol. 83(4):322-29.